-
Hodgkins, P, Setyawan, J, Banaschewski, T, Soutullo, C, Lecendreux, M, Johnson, M, Zuddas, A, Adeyi, B, Squires, LA, Coghill, DR.
EPA-0993 – Health utility scores in children and adolescents with attention-deficit/hyperactivity disorder: response to stimulant treatment.
European Psychiatry
29:
1
2014
view publication
-
Banaschewski, T, Soutullo, C, Lecendreux, M, Johnson, M, Zuddas, A, Hodgkins, P, Adeyi, B, Squires, LA, Coghill, DR.
EPA-1078 – The child health and illness profile as a measure of health-related quality of life in stimulant-treated children and adolescents with ADHD.
European Psychiatry
29:
1
2014
view publication
-
Coghill, DR, Banaschewski, T, Lecendreux, M, Soutullo, C, Johnson, M, Zuddas, A, Anderson, C, Civil, R, Dauphin, M, Lyne, A, et al.
EPA-1407 – The first European studies of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
European Psychiatry
29:
1
2014
view publication
-
Dittmann, RW, Cardo, E, Nagy, P, Anderson, CS, Bloomfield, R, Caballero, B, Higgins, N, Hodgkins, P, Lyne, A, Civil, R, et al.
Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study..
CNS Drugs
27(12)
:
1081 -1092
2013
view publication
-
Johnston, BA, Mwangi, B, Matthews, K, Coghill, D, Steele, JD.
Predictive classification of individual magnetic resonance imaging scans from children and adolescents..
Eur Child Adolesc Psychiatry
22(12)
:
733 -744
2013
view publication